Market Overview:
The Hyperthermia Cancer Treatment Market involves the use of heat therapy to treat cancerous tumors. Cancer cells are more sensitive to heat than normal cells and hyperthermia takes advantage of this sensitivity by exposing tumors to temperatures slightly higher than normal body temperature (usually 42-45°C), damaging and killing cancer cells or making them more vulnerable to radiation therapy and chemotherapy. This noninvasive treatment can be used alone or combined with chemotherapy, radiation therapy, or surgery and has minimal side effects compared to other cancer treatments.
Market key trends:
One of the key trends in the Hyperthermia Cancer Treatment Market is the increasing adoption of magnetic hyperthermia methods that use magnetic nanoparticles to generate heat inside tumors upon exposure to an alternating magnetic field. Magnetic hyperthermia provides improved targeting of heat to tumors with minimal side effects. Companies are developing advanced magnetic nanoparticle formulations and systems to optimize magnetic hyperthermia treatment efficacy. For example, MagForce AG offers the NanoTherm therapy system that uses thermotherapy in conjunction with its liquid nanothermic agents to treat brain and prostate tumors.
The global Hyperthermia Cancer Treatment Market Demand is estimated to be valued at US$ 187.05 Billion in 2023 and is expected to exhibit a CAGR of 6.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Segment Analysis
The global Hyperthermia Cancer Treatment market is segmented by type, application, modality, and region. Based on type, the market is segmented into microwave hyperthermia devices, ultrasound hyperthermia devices, infrared hyperthermia devices, and other devices. Among these, the microwave hyperthermia devices segment dominated the market in 2023, accounting for around 35% of the total market share. Microwave hyperthermia devices use electromagnetic waves to generate heat inside the tumor and this technology allows for more precise temperature control and deeper penetration depth compared to other modalities, which has driven its higher adoption.
Key Takeaways
The global Hyperthermia Cancer Treatment market is expected to witness high growth, exhibiting a CAGR of 6.1% over the forecast period of 2023 to 2030, due to increasing incidence of cancer globally.
The US region currently dominates the global market and is expected to continue its dominance over the forecast period. This is attributed to growing awareness regarding non-invasive cancer treatment options and favorable reimbursement policies in the country. However, the Asia Pacific region is projected to exhibit the highest CAGR during the analysis period, led by rapidly increasing healthcare expenditure and presence of untapped opportunities in emerging countries of China and India.
Key players operating in the Hyperthermia Cancer Treatment market are MagForce AG, Andromedic, Xianke Medical Equipment, OncoTherm, Celsius42+, Oncotherm, Pyrexar Medical, Yamamoto Vinita, Nanoprobes, Alba Hyperthermia System, Nova Company, Perseon, Omron, Sunny Medical Equipment, OrienTech, BSD Medical, Sensius, Celsius42, Nanjing Greathope, Shanghai Huayuan. Major players are focusing on new product launches, collaborations and geographic expansions to garner higher market share.
Read More: https://www.dailyprbulletin.com/magforce-ag-leading-hyperthermia-cancer-treatment-market-growth/
It includes the size, share, growth, trends, key players, segments and regional analysis in detail during the study year 2020-2027.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the hyperthermia cancer treatment market include Pyrexar Medical, Celsius42 GmbH, Hydrosun GmbH, Oncotherm Kft, Andromedic S.r.l., Yamamoto Vinita Co., Ltd., Chongqing Haifu Medical Technology Co., Ltd., innoMedicus Ltd., Gamida, and RanD.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Hyperthermia Cancer Treatment Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/hyperthermia-cancer-treatment-market/download-sampleMarket DynamicsThe global hyperthermia cancer treatment market is at its nascent stage.
Mounting cancer burden worldwide and spurring research on its effectiveness is projected to propel the demand for hyperthermia cancer treatment.
Numerous clinical trials have examined hyperthermia in combination with chemotherapy and radiation therapy.
The research has witnessed improved and progressive results favorable for commercial use, creating lucrative opportunities for the market.
